Transdermal Drug Delivery System Market -  Share Report, 2032

Transdermal Drug Delivery Systems Market - By Type (Transdermal Patches, Transdermal Semisolids) By Application (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases) By End-use & Forecast to 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope and definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates and working

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Transdermal drug delivery systems industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Type trends

2.1.3&nbsp;&nbsp;&nbsp; Application trends

2.1.4&nbsp;&nbsp;&nbsp; End-use trends

2.1.5&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Transdermal Drug Delivery Systems Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp;Increasing prevalence of chronic diseases

3.3.1.2&nbsp;&nbsp;&nbsp;Increasing adoption of transdermal patches

3.3.1.3&nbsp;&nbsp;&nbsp;Growing demand for non-invasive drug delivery system

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp;Limited number of approved medications

3.3.2.2&nbsp;&nbsp;&nbsp;High cost involved in development of drug delivery systems

3.4&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4.1&nbsp;&nbsp;&nbsp; By type

3.4.2&nbsp;&nbsp;&nbsp; By application

3.4.3&nbsp;&nbsp;&nbsp; By end-use

3.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.6&nbsp;&nbsp;&nbsp; Regulatory landscape

3.7&nbsp;&nbsp;&nbsp; Advancement in transdermal drug delivery systems

3.8&nbsp;&nbsp;&nbsp; Transdermal forms containing the specified active substance, %

3.9&nbsp;&nbsp;&nbsp; Pricing analysis, by type, 2022

3.10&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.11&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2021

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2021

4.3&nbsp;&nbsp;&nbsp; Company positioning matrix

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Strategic outlook matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2021

Chapter 5&nbsp;&nbsp;&nbsp;Transdermal Drug Delivery Systems Market, By Type

5.1&nbsp;&nbsp;&nbsp; Key type trends

5.2&nbsp;&nbsp;&nbsp; Transdermal patches

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.2&nbsp;&nbsp;&nbsp; Drug-in-adhesive patches

5.2.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.3&nbsp;&nbsp;&nbsp; Matrix patches

5.2.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.4&nbsp;&nbsp;&nbsp; Reservoir membrane patches

5.2.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.5&nbsp;&nbsp;&nbsp; Microneedle patches

5.2.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Transdermal semisolids

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.2&nbsp;&nbsp;&nbsp; Gels

5.3.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.3&nbsp;&nbsp;&nbsp; Ointments

5.3.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.4&nbsp;&nbsp;&nbsp; Sprays

5.3.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Transdermal Drug Delivery Systems Market, By Application

6.1&nbsp;&nbsp;&nbsp; Key application trends

6.2&nbsp;&nbsp;&nbsp; Pain management

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Hormonal application

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Central nervous system disorders

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Cardiovascular diseases

6.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.6&nbsp;&nbsp;&nbsp; Others

6.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Transdermal Drug Delivery Systems Market, By End-use

7.1&nbsp;&nbsp;&nbsp; Key end-use trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Clinics

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.4&nbsp;&nbsp;&nbsp; Homecare settings

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.5&nbsp;&nbsp;&nbsp; Others

7.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Transdermal Drug Delivery Systems Market, By Region

8.1&nbsp;&nbsp;&nbsp; Key regional trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Italy

8.3.5&nbsp;&nbsp;&nbsp; Spain

8.3.6&nbsp;&nbsp;&nbsp; Poland

8.3.7&nbsp;&nbsp;&nbsp; Switzerland

8.3.8&nbsp;&nbsp;&nbsp; The Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; Japan

8.4.2&nbsp;&nbsp;&nbsp; China

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Indonesia

8.4.7&nbsp;&nbsp;&nbsp; Thailand

8.4.8&nbsp;&nbsp;&nbsp; Vietnam

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Peru

8.5.5&nbsp;&nbsp;&nbsp; Colombia

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Israel

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Novartis

9.2&nbsp;&nbsp;&nbsp; Mylan

9.3&nbsp;&nbsp;&nbsp; Amneal Pharmaceuticals, Inc

9.4&nbsp;&nbsp;&nbsp; Zydus Pharmaceuticals, Inc

9.5&nbsp;&nbsp;&nbsp; UCB

9.6&nbsp;&nbsp;&nbsp; Hisamitsu Pharmaceutical Co.,Inc

9.7&nbsp;&nbsp;&nbsp; Corium, Inc.

9.8&nbsp;&nbsp;&nbsp; Micropoint Technologies.

9.9&nbsp;&nbsp;&nbsp; Sparsha Pharma International Pvt. Ltd.

9.10&nbsp;&nbsp;&nbsp; Luye pharma 
&nbsp;

Transdermal Drug Delivery Systems Market

Get a free sample of this report